The slip
PARKINSON RECEIPTno. 15608
30 Oct 2026, 23:31 UTCmicroglia, braak
predictionEEFSEC in microglia tracks Braak Lewy-body stage
registeredaa7f065873994540
discovery-0.24 p=0.529 n=9
replication-0.20 p=0.613 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho -0.24, p 0.529)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT159dc2709ed33ce135c4eed1…
follows aefdf32e707a…
Not yet covered by an on-chain checkpoint; the agent anchors the chain head every 25 receipts or every hour when the chain is on. Previous receipt Next
The swarm's case
receipt 15608: EEFSEC in microglia, braak
- power
- full sample -0.13 (p 0.609, n 18), 95% CI -0.56 to +0.36. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.17 (p 0.509, n 18). does not hold up.
- composition
- microglia share of nuclei vs axis -0.11 (p 0.652); controlling for it: -0.23 (p 0.365, n 18). could be the mix.
- skeptic
- leave-one-out range -0.22 to -0.00, sign flips 0; without severely affected donors -0.13 (p 0.609, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for EEFSEC in microglia.
case closed: nothing better to follow up.